TY - JOUR
T1 - A mouse model of humanized liver shows a human-like lipid profile, but does not form atherosclerotic plaque after western type diet
AU - Sari, Gulce
AU - Meester, Eric J.
AU - van der Zee, Leonie C.
AU - Wouters, Kristiaan
AU - van Lennep, Jeanine R.
AU - Peppelenbosch, Maikel
AU - Boonstra, Andre
AU - Van der Heiden, Kim
AU - Mulder, Monique M. T.
AU - Vanwolleghem, Thomas
N1 - Funding Information:
This study was supported by a 2014 MRace Pilot Grant from the Erasmus University Medical Center .
Publisher Copyright:
© 2020 The Authors
PY - 2020/4/2
Y1 - 2020/4/2
N2 - Mouse models are a crucial and often used tool to provide insight into the underlying mechanisms of human atherosclerosis. However, mice profoundly differ from humans in lipoprotein synthesis and metabolism, key factors in atherosclerotic plaque formation. Mouse models often require genetic and dietary modifications to mimic human pathophysiology, shifting from a high-density lipoprotein to an low-density lipoprotein dominant lipoprotein profile. We examined the suitability of mice with a humanized liver as a model for lipoprotein studies and studies on plaque formation, given the central role of hepatocytes in lipoprotein synthesis and metabolism. Our results show a progressive humanization of the mouse liver and a humanized lipoprotein profile. However, no atherosclerotic plaque formation was observed in the studied time frame, despite presence of functional macrophages and application of a high cholesterol western-type diet. The humanized-liver mouse model therefore might require further modifications to induce atherosclerosis, yet seems a valuable model for in vivo studies on lipoprotein metabolism. (C) 2020 The Authors. Published by Elsevier Inc.
AB - Mouse models are a crucial and often used tool to provide insight into the underlying mechanisms of human atherosclerosis. However, mice profoundly differ from humans in lipoprotein synthesis and metabolism, key factors in atherosclerotic plaque formation. Mouse models often require genetic and dietary modifications to mimic human pathophysiology, shifting from a high-density lipoprotein to an low-density lipoprotein dominant lipoprotein profile. We examined the suitability of mice with a humanized liver as a model for lipoprotein studies and studies on plaque formation, given the central role of hepatocytes in lipoprotein synthesis and metabolism. Our results show a progressive humanization of the mouse liver and a humanized lipoprotein profile. However, no atherosclerotic plaque formation was observed in the studied time frame, despite presence of functional macrophages and application of a high cholesterol western-type diet. The humanized-liver mouse model therefore might require further modifications to induce atherosclerosis, yet seems a valuable model for in vivo studies on lipoprotein metabolism. (C) 2020 The Authors. Published by Elsevier Inc.
KW - Human liver chimeric mouse model
KW - Atherosclerosis
KW - High fat diet
KW - Lipoprotein
KW - Cardiovascular disease
KW - HUMAN HEPATOCYTES
KW - VIRUS-INFECTION
KW - CHIMERIC MICE
KW - C VIRUS
KW - THERAPY
U2 - 10.1016/j.bbrc.2020.01.067
DO - 10.1016/j.bbrc.2020.01.067
M3 - Article
C2 - 32014257
SN - 0006-291X
VL - 524
SP - 510
EP - 515
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -